It’s getting harder to claim success with weight reduction drugs
1 week, 1 day ago

It’s getting harder to claim success with weight reduction drugs

Live Mint  

In a new study, an experimental obesity drug from Novo Nordisk, CagriSema allowed people to lose more than 20% of their body weight, on average, a result that caused the Danish company’s stock price to fall by as much as 29%. CagriSema is a combination of the GLP-1 agonist semaglutide, the ingredient found in Novo’s Ozempic and Wegovy, and cagrilintide, which mimics two hormones, amylin and calcitonin, that also help control feelings of satiety. Earlier, Lilly said that Zepbound handily beat Wegovy in a head-to-head trial of the two drugs, with its drug offering 20% weight loss compared with Wegovy’s 14%. Between those two issues, “the underwhelming result will likely pressure consensus, which sees the asset driving almost 20% of Novo’s sales in 2030," Bloomberg Intelligence analysts said following the news.

Drugs Obesity Weight Drug Study Wegovy Novo Zepbound Lilly Cagrisema  drug  drugs  success  study  stock  novos  likely  weight  claim  investors  obesity  reduction  harder  zepbound  getting

History of this topic

Why the Obesity Drug Revolution Is a Work in Progress
1 week ago

Why the Obesity Drug Revolution Is a Work in Progress

Bloomberg  

A new class of weight-loss drugs known as GLP-1s are proving to be game changers for people with obesity. They’re also minting billions for pharmaceutical companies, especially the companies that developed them, Eli Lilly & Co. and Novo Nordisk A/S. It also remains unclear whether pharma companies can actually deliver on the promise of even better weight-loss drugs — part …

Junk food companies 'freaking out' as people on weight-loss meds eat better: columnist
1 week, 1 day ago

Junk food companies 'freaking out' as people on weight-loss meds eat better: columnist

Raw Story  

Junk food companies are starting to get nervous over how many Americans use GLP-1 medications to lose weight. Washington Post columnist Catherine Rampell walked through shocking details of the economic impact of drugs like Wegovy and Ozempic cited in a new study by Cornell University and Numerator. Meanwhile, the Danish pharmaceutical company Novo Nordisk, which makes Ozempic and Wegovy, made …

Novo Nordisk’s share plunges 19.5% post release of weight loss drug CagriSema’s trial results
2 weeks, 6 days ago

Novo Nordisk’s share plunges 19.5% post release of weight loss drug CagriSema’s trial results

Live Mint  

The experimental next-generation obesity drug CagriSema helped overweight patients cut their weight by 22.7 percent in a late-stage trial, Reuters quoted Novo Nordisk as saying on Friday, adding the results were 25 percent they had expected. The new findings from the drug candidate deals a blow to the Danish drugmaker's ambitions for a successor to its popular Wegovy more powerful …

Consultations for obesity drug prescriptions are way up over 2023, survey finds
4 weeks ago

Consultations for obesity drug prescriptions are way up over 2023, survey finds

NPR  

Consultations for obesity drug prescriptions are way up over 2023, survey finds Appointments with health professionals for obesity drug consultations are way up, according to data from Zocdoc, a provider of scheduling services. SYDNEY LUPKIN, BYLINE: Doctor Sarah Nosal, a family physician in the South Bronx, New York, says a lot more of her patients have come in asking about …

Eli Lilly new trial is all about the battle to be best weight-loss drug zepbound and wegovy
1 month ago

Eli Lilly new trial is all about the battle to be best weight-loss drug zepbound and wegovy

India Today  

In a study trial, pharmaceutical giant Eli Lilly's weight-loss drug Zepbound showed better results than another pharmaceutical company, Novo Nordisk's weight-loss drug Wegovy. The trial, called SURMOUNT-5, compared Zepbound to Wegovy, which is a mono GLP-1 receptor agonist in adults living with obesity without diabetes. The results showed Zepbound delivering a remarkable 47% greater relative weight loss compared to Wegovy, …

Weight-loss meds go head-to-head in new study. One was significantly more effective, drugmaker says
1 month ago

Weight-loss meds go head-to-head in new study. One was significantly more effective, drugmaker says

The Independent  

Sign up to our free Living Well email for advice on living a happier, healthier and longer life Live your life healthier and happier with our free weekly Living Well newsletter Live your life healthier and happier with our free weekly Living Well newsletter SIGN UP I would like to be emailed about offers, events and updates from The Independent. …

Zepbound tops Wegovy for weight loss in Eli Lilly study
1 month ago

Zepbound tops Wegovy for weight loss in Eli Lilly study

Associated Press  

Share Share Copy Link copied Email Facebook X Reddit LinkedIn Pinterest Flipboard Print Shares of Eli Lilly climbed Wednesday after the drugmaker detailed a study showing that its blockbuster weight-loss drug Zepbound helped patients shed more pounds than Wegovy from rival Novo Nordisk. Lilly said patients taking Zepbound lost about 20% of their weight on average compared to nearly 14% …

Eli Lilly’s Zepbound beats Novo Nordisk’s Wegovy in first head-to-head study
1 month ago

Eli Lilly’s Zepbound beats Novo Nordisk’s Wegovy in first head-to-head study

Live Mint  

In the first head-to-head test, Eli Lilly’s Zepbound obesity drug helped people lose significantly more weight than its main competitor, Novo Nordisk’s Wegovy. The details People taking Zepbound lost 20.2% of their body weight on average after 72 weeks of treatment in the Lilly- That translated into an average 50-pound loss for people who took Zepbound, while Wegovy users lost …

Weight loss drug battle heats up as Wegovy beaten in head-to-head trial
1 month ago

Weight loss drug battle heats up as Wegovy beaten in head-to-head trial

The Independent  

Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Get our free Health Check email SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy A rival drug company is celebrating results claiming its drug helps …

Eli Lilly and Novo Nordisk’s obesity moat just got stronger
1 month, 1 week ago

Eli Lilly and Novo Nordisk’s obesity moat just got stronger

Live Mint  

The obesity duopoly has been pierced as Amgen positions itself to have a drug on the market in a few years. Not only did MariTide fail to outperform Lilly’s Zepbound, but both Lilly and Novo also have next-generation medications under development, with promising data showing even more impressive weight loss results. “A 20% weight loss would have been best-in-class if …

Cheap Ozempic? Millions of obese Americans wait on Trump’s decision
1 month, 1 week ago

Cheap Ozempic? Millions of obese Americans wait on Trump’s decision

The Independent  

The latest headlines from our reporters across the US sent straight to your inbox each weekday Your briefing on the latest headlines from across the US Your briefing on the latest headlines from across the US SIGN UP I would like to be emailed about offers, events and updates from The Independent. The rule, unveiled on Tuesday by the Health …

Cheap Ozempic? How millions of Americans with obesity may get access to costly weight-loss drugs
Trending News
1 month, 1 week ago

Cheap Ozempic? How millions of Americans with obesity may get access to costly weight-loss drugs

Associated Press  

WASHINGTON — Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $ 35 billion proposal from the Biden administration is blessed by President-elect Donald Trump. The rule, unveiled Tuesday by the Health and Human Services Department, would require Medicare and Medicaid to cover weight-loss drugs like Wegovy or Zepbound …

What happens when Ozempic and Wegovy don’t work?
1 month, 2 weeks ago

What happens when Ozempic and Wegovy don’t work?

The Independent  

Sign up to our free Living Well email for advice on living a happier, healthier and longer life Live your life healthier and happier with our free weekly Living Well newsletter Live your life healthier and happier with our free weekly Living Well newsletter SIGN UP I would like to be emailed about offers, events and updates from The Independent. …

Weight-loss drug Wegovy launched in China
1 month, 3 weeks ago

Weight-loss drug Wegovy launched in China

CNN  

Novo Nordisk said Monday it has launched its popular obesity drug Wegovy in China, the world’s second-largest pharmaceuticals market where it estimates more than 180 million people live with obesity. Novo gained approval for Wegovy in China in June and will initially target Chinese patients willing to pay out-of-pocket for the weekly injectable drug. Strong sales there and in the …

Wegovy/Mounjaro: The UK thinks weight loss drugs could ease unemployment. Experts say that’s a fantasy
Trending News
1 month, 3 weeks ago

Wegovy/Mounjaro: The UK thinks weight loss drugs could ease unemployment. Experts say that’s a fantasy

CNN  

London CNN — Weight loss drugs such as Wegovy and Ozempic have been hailed worldwide as revolutionary for medicine. British Prime Minister Keir Starmer has said that his government needs to “think differently” about how to reduce pressure on the country’s national health care system, overburdened amid staffing shortages and funding pressures. Tom Little/Reuters The government trial studying links between …

Obesity Pill Data Portend Competition, Hitting Drugmaker Shares
2 months ago

Obesity Pill Data Portend Competition, Hitting Drugmaker Shares

Live Mint  

-- Obesity pill data released by Viking Therapeutics Inc. and AstraZeneca Plc at a big conference foreshadowed an increasingly competitive landscape for weight-loss therapies, sending down shares of drugmakers in the field. Effectiveness and safety data from Viking’s study, released Sunday at an industry conference, show that an obesity pill could be a reality soon: People who took 100-milligram doses …

Big Pharma’s obesity bonanza faces new tests
2 months ago

Big Pharma’s obesity bonanza faces new tests

Live Mint  

In terms of recent stock-market frenzies, the Ozempic trade nearly tops the list, second only to speculation that artificial intelligence will soon be writing this column. Powerful weight-loss drugs like Wegovy and Zepbound have driven nearly $1 trillion in market-capitalization gains, with most of those gains flowing to Eli Lilly and Novo Nordisk, the dominant players in the obesity-drug market. …

Ozempic, Wegovy considered ‘available’ after more than 2 years in shortage
2 months, 1 week ago

Ozempic, Wegovy considered ‘available’ after more than 2 years in shortage

The Independent  

Sign up to our free Living Well email for advice on living a happier, healthier and longer life Live your life healthier and happier with our free weekly Living Well newsletter Live your life healthier and happier with our free weekly Living Well newsletter SIGN UP I would like to be emailed about offers, events and updates from The Independent. …

Influencers are being offered tens of thousands of dollars to hawk weight-loss drugs
2 months, 1 week ago

Influencers are being offered tens of thousands of dollars to hawk weight-loss drugs

The Independent  

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Sign up to our free breaking news emails SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy Influencers have been offered tens …

The US has passed peak obesity, a new survey suggests. Is it the Ozempic effect?
3 months ago

The US has passed peak obesity, a new survey suggests. Is it the Ozempic effect?

The Independent  

Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, events and updates from The Independent. Please try again later {{ /verifyErrors }} The United …

Eli Lilly is gaining on Novo Nordisk in the obesity race
4 months, 4 weeks ago

Eli Lilly is gaining on Novo Nordisk in the obesity race

Live Mint  

The two companies’ divergent earnings reports this week showed that Indianapolis-based Lilly is moving faster than its Denmark-headquartered counterpart in the race to win the GLP-1 war. Less than a year after approval, Eli Lilly’s weekly prescription volume of Zepbound is about where Novo was with Wegovy volume more than two years in, according to JPMorgan data. And while all …

Rivals emerge to Ozempic and Zepbound—but with a lag
5 months, 2 weeks ago

Rivals emerge to Ozempic and Zepbound—but with a lag

Live Mint  

The two dominant players in the obesity market will eventually make way for a few more competitors. On Wednesday, Roche’s stock gained 5.6%, adding roughly $14 billion to its market value, after it reported that Carmot’s once-daily pill helped patients lose 7.3% of their body weight at the four-week mark. While the data was from an early-stage study, it was …

India one step closer to approving weight-loss drug tirzepatide: What is it? How does it work?
5 months, 3 weeks ago

India one step closer to approving weight-loss drug tirzepatide: What is it? How does it work?

Firstpost  

Eli Lilly, the pharmaceutical company, has received the first approval for the sale of its blockbuster drug Tirzepatide in India. Here’s what we know about this ‘game-changing’ medication A box of Mounjaro, a tirzepatide injection drug used for treating type 2 diabetes made by Lilly is seen at Rock Canyon Pharmacy in Provo, Utah. Last week, the apex drug regulator’s, …

Weight-loss war heats up as Wegovy rival found to lead to faster and greater results
5 months, 4 weeks ago

Weight-loss war heats up as Wegovy rival found to lead to faster and greater results

The Independent  

Sign up to our free Living Well email for advice on living a happier, healthier and longer life Live your life healthier and happier with our free weekly Living Well newsletter Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, events and updates from The Independent. Please …

Wegovy weight-loss drug OK'd in China
6 months, 2 weeks ago

Wegovy weight-loss drug OK'd in China

China Daily  

FILE PHOTO: A view shows the logo of Novo Nordisk at the company's office in Bagsvaerd, on the outskirts of Copenhagen, Denmark, March 8, 2024. Danish drugmaker Novo Nordisk said Tuesday that its injectable weight-loss drug Wegovy has been approved in China, where the proportion of overweight and obese adults reached almost 51 percent of the country's 1.4 billion people …

Wegovy weight-loss drug OK'd in China
6 months, 2 weeks ago

Wegovy weight-loss drug OK'd in China

China Daily  

By AI HEPING in New York | chinadaily.com.cn | Updated: 2024-06-26 14:54 FILE PHOTO: A view shows the logo of Novo Nordisk at the company's office in Bagsvaerd, on the outskirts of Copenhagen, Denmark, March 8, 2024. Danish drugmaker Novo Nordisk said Tuesday that its injectable weight-loss drug Wegovy has been approved in China, where the proportion of overweight and …

In China, weight-loss drugs are becoming big business
7 months ago

In China, weight-loss drugs are becoming big business

Al Jazeera  

Chinese pharmaceutical companies are racing to roll out weight-loss drugs amid the popularity of Ozempic. Ozempic was approved in China to treat diabetes in 2021, but it has been its anti-obesity ingredient, semaglutide, that has fuelled demand for what many Chinese refer to as the “internet celebrity weight-loss drug”. “Weight-loss drugs fall within a market with massive growth potential in …

Wegovy: At least 25,000 people in the US are starting weight-loss drug each week, drugmaker says
8 months, 1 week ago

Wegovy: At least 25,000 people in the US are starting weight-loss drug each week, drugmaker says

CNN  

CNN — Drugmaker Novo Nordisk said it’s been increasing supply of its sought-after weight-loss drug Wegovy, with at least 25,000 people now starting to take the medicine each week in the United States. We’re talking about, many patients, chronic treatment.” Eli Lilly, Novo Nordisk’s biggest competitor, also said this week it expects supply to increase later this year. “While we …

The Ozempic Effect: How a Weight Loss Wonder Drug Gobbled Up an Entire Economy
8 months, 1 week ago

The Ozempic Effect: How a Weight Loss Wonder Drug Gobbled Up an Entire Economy

Bloomberg  

There is no escaping Ozempic and Wegovy. They’ve won over the rich and famous, generated billions in sales and blown open a new market for weight loss drugs, which Goldman Sachs estimates will reach $100 billion a year by 2030. The development of semaglutide, the key ingredient in the medicines, has also transformed their maker, Novo Nordisk, into Europe’s most …

Why weight-loss drugs will reshape the world
8 months, 3 weeks ago

Why weight-loss drugs will reshape the world

The Economist  

Listen to this podcast Your browser does not support the <audio> element. Both make the “miracle” drugs that can help people shed up to a fifth of their body weight. Guests: The Economist’s Georgia Banjo; pharmaceuticals analyst Michael Nedelcovych; and John Cawley, a professor of public policy and economics at Cornell University. Subscribers to Economist Podcasts+ can listen to our …

‘Miracle’ weight-loss drugs could have reduced health disparities. Instead they got worse
8 months, 3 weeks ago

‘Miracle’ weight-loss drugs could have reduced health disparities. Instead they got worse

LA Times  

Wegovy is part of a new generation of weight-loss medications that made some doctors optimistic about reversing longstanding racial and ethnic disparities in obesity. “These patients have a higher burden of disease, and they’re less likely to get the medicine that can save their lives,” said Dr. Lauren Eberly, a cardiologist and health services researcher at the University of Pennsylvania. …

Drugs like Ozempic and Wegovy could boost the US economy by a trillion dollars in a few years, Goldman Sachs predicts
10 months, 1 week ago

Drugs like Ozempic and Wegovy could boost the US economy by a trillion dollars in a few years, Goldman Sachs predicts

CNN  

Washington, DC CNN — The US economy is set to reap considerable benefits from Americans taking popular medications used for weight loss, including Ozempic and Wegovy, Goldman Sachs analysts wrote in a recent research report. Goldman Sachs argues that since poor health unambiguously weighs on the economy, improving health outcomes due to GLP-1s could lower costs and boost productivity, shoring …

Weight loss, diabetes drugs propel Eli Lilly to largely better-than-expected forecast for 2024
11 months ago

Weight loss, diabetes drugs propel Eli Lilly to largely better-than-expected forecast for 2024

Associated Press  

Eli Lilly rode soaring demand for diabetes and weight-loss treatments to a better-than-expected finish in 2023, and the drugmaker expects momentum to carry into the new year. Lilly said on Tuesday that revenue could climb as much as 22% this year, as star sellers like the diabetes drug Mounjaro and its new weight-loss counterpart, Zepbound, gain market share. Zepbound, a …

Big Pharma scrambles to feed demand for weight-loss treatments amid rising US obesity rates
1 year, 1 month ago

Big Pharma scrambles to feed demand for weight-loss treatments amid rising US obesity rates

Associated Press  

NEW YORK — Obesity rates in the U.S. have been rising steadily for well over a decade and some of the world’s biggest drug developers are tapping into the growing treatment market. It notably priced the drug at roughly a 20% discount to Novo Nordisk’s Wegovy as the companies try to entice more employers to include weight-loss drugs in their …

AstraZeneca joins obesity drug craze as it signs £1.6bn deal with Chinese medical group
1 year, 1 month ago

AstraZeneca joins obesity drug craze as it signs £1.6bn deal with Chinese medical group

Daily Mail  

AstraZeneca has entered the race to develop a weight-loss drug after striking a £1.6billion deal with a Chinese medical group. China deal: AstraZeneca boss Pascal Soriot said that the move into weight loss drugs follows 'enormous need around the world' Details emerged just hours after it was revealed that AstraZeneca is facing a multi-million-pound legal battle over claims the efficacy …

Lilly weight-loss drug Zepbound gets US, UK approval to rival Wegovy
1 year, 2 months ago

Lilly weight-loss drug Zepbound gets US, UK approval to rival Wegovy

Hindustan Times  

U.S. and UK regulators both gave the thumbs up to Eli Lilly's weight-loss treatment called Zepbound on Wednesday, paving the way for a powerful new rival to Novo Nordisk's Wegovy in addressing record obesity rates. U.S. and UK regulators approved the Lilly drug for use by adults with a body mass index - a measure of weight based on height …

A new version of the diabetes drug Mounjaro can be used for weight loss, FDA says
1 year, 2 months ago

A new version of the diabetes drug Mounjaro can be used for weight loss, FDA says

Associated Press  

A new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug, U.S. regulators announced Wednesday. Zepbound is the latest diabetes drug approved for chronic weight management, joining Novo Nordisk’s Wegovy, a high-dose version of its diabetes treatment Ozempic. “This would be the most highly efficacious drug ever approved for the treatment of obesity,” said Dr. …

Supply problems and insurance issues make popular weight-loss drugs hard to get
1 year, 3 months ago

Supply problems and insurance issues make popular weight-loss drugs hard to get

Associated Press  

When she prescribes the popular weight-loss drug Wegovy, Dr. Angela Fitch sends patients on a quest she likens to “The Hunger Games.” They will have to call drugstores over several days to find one with the properly sized first dose. Supply problems and insurance complications have made it difficult for people to start — and stay on — Wegovy and …

How does Wegovy work? The ‘game changing’ weight loss drug beloved by Hollywood
1 year, 4 months ago

How does Wegovy work? The ‘game changing’ weight loss drug beloved by Hollywood

The Independent  

Sign up to our free Living Well email for advice on living a happier, healthier and longer life Live your life healthier and happier with our free weekly Living Well newsletter Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, events and updates from The Independent. Please …

The obesity drugs waiting to hit the market
1 year, 5 months ago

The obesity drugs waiting to hit the market

The Hindu  

Novo Nordisk said a large study had shown its highly effective obesity drug Wegovy also had a clear cardiovascular benefit, boosting the Danish drugmaker’s hopes of moving beyond Wegovy’s image as a lifestyle drug. The following is a list of companies targeting the next big blockbuster opportunity: Novo Nordisk said a large study had shown its highly effective obesity drug, …

Obesity drug Wegovy reduces heart attacks and strokes risk by 20%, shows study
1 year, 5 months ago

Obesity drug Wegovy reduces heart attacks and strokes risk by 20%, shows study

Hindustan Times  

Novo Nordisk A/S shares surged to a record after the Danish company’s blockbuster obesity medicine Wegovy reduced the risk of heart attacks and strokes in a highly anticipated study, giving it another potential boost. Obesity drug Wegovy reduces heart attacks and strokes risk by 20%, shows study Patients with obesity or overweight and with a history of cardiovascular issues taking …

Powerful new obesity drug poised to upend weight loss care
1 year, 8 months ago

Powerful new obesity drug poised to upend weight loss care

Associated Press  

As a growing number of overweight Americans clamor for Ozempic and Wegovy — drugs touted by celebrities and on TikTok to pare pounds — an even more powerful obesity medicine is poised to upend treatment. Tirzepatide, an Eli Lilly and Co. drug approved to treat type 2 diabetes under the brand name Mounjaro, helped people with the disease who were …

Powerful new obesity drug poised to upend weight loss care
1 year, 8 months ago

Powerful new obesity drug poised to upend weight loss care

The Independent  

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, events and updates from The Independent. Tirzepatide, an Eli Lilly and …

What to know about prescription drugs promising weight loss
1 year, 10 months ago

What to know about prescription drugs promising weight loss

Associated Press  

WeightWatchers, the 60-year-old diet firm, announced this week it would acquire a telehealth company whose providers prescribe anti-obesity drugs for growing numbers of eager online subscribers. The $132 million deal with Sequence is the just the latest commercial push into the red-hot market for prescription drugs that promise significant weight loss. In a clinical trial, adults who took Wegovy saw …

What is Wegovy, the controversial new weight loss drug beloved by celebrities?
1 year, 10 months ago

What is Wegovy, the controversial new weight loss drug beloved by celebrities?

The Independent  

Sign up to our free Living Well email for advice on living a happier, healthier and longer life Live your life healthier and happier with our free weekly Living Well newsletter Live your life healthier and happier with our free weekly Living Well newsletter SIGN UP I would like to be emailed about offers, events and updates from The Independent. …

What is the new wonder weight loss drug?
1 year, 10 months ago

What is the new wonder weight loss drug?

The Independent  

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Sign up to our free breaking news emails SIGN UP I would like to be emailed about offers, events and updates from The Independent. The patient information leaflet for the drug states that …

WeightWatchers gets into prescription weight loss business
1 year, 10 months ago

WeightWatchers gets into prescription weight loss business

Associated Press  

WeightWatchers’ stock soared Tuesday after the company said it is getting into the prescription drug weight loss business with the acquisition of Sequence. Sequence is a telehealth provider that offers users access to drugs used to treat diabetes and obesity under the brand names including Ozempic, Wegovy and Trulicity. “This deal brings access to prescription drug solutions for weight loss …

A new class of drugs for weight loss could end obesity
1 year, 10 months ago

A new class of drugs for weight loss could end obesity

Live Mint  

How did Kim Kardashian, a reality tv star, lose enough weight to fit into a slinky dress once worn by Marilyn Monroe? Fatima Stanford, who studies obesity at Massachusetts General Hospital and Harvard Medical School, notes that attempts to lose weight through diet and exercise work for only 10-20% of the population: “For most people we don’t see a dramatic …

Wegovy: What you need to know about the weight loss drug set to be sold in pharmacies
1 year, 10 months ago

Wegovy: What you need to know about the weight loss drug set to be sold in pharmacies

The Independent  

Sign up to our free Living Well email for advice on living a happier, healthier and longer life Live your life healthier and happier with our free weekly Living Well newsletter Live your life healthier and happier with our free weekly Living Well newsletter SIGN UP I would like to be emailed about offers, events and updates from The Independent. …

Discover Related